[go: up one dir, main page]

ES2052681T3 - Combinacion sinergica de inhibidores de descarboxilasa y granulos de l-dopa. - Google Patents

Combinacion sinergica de inhibidores de descarboxilasa y granulos de l-dopa.

Info

Publication number
ES2052681T3
ES2052681T3 ES88120859T ES88120859T ES2052681T3 ES 2052681 T3 ES2052681 T3 ES 2052681T3 ES 88120859 T ES88120859 T ES 88120859T ES 88120859 T ES88120859 T ES 88120859T ES 2052681 T3 ES2052681 T3 ES 2052681T3
Authority
ES
Spain
Prior art keywords
dopa
granules
decarboxylase inhibitors
synergic combination
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88120859T
Other languages
English (en)
Other versions
ES2052681T5 (es
Inventor
Manfred Dr Albring
Helmut Dr Hettche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asta Medica GmbH
Original Assignee
Asta Medica GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6343914&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2052681(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Asta Medica GmbH filed Critical Asta Medica GmbH
Application granted granted Critical
Publication of ES2052681T3 publication Critical patent/ES2052681T3/es
Publication of ES2052681T5 publication Critical patent/ES2052681T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMBINACION SINERGETICA DE L-DOPA-PELLETS E INHIBIDORES DE DECARBOXILASA COMO MEDICAMENTO CONTRA LA ENFERMEDAD DE PARKINSON.
ES88120859T 1987-12-31 1988-12-14 Combinacion sinergica de inhibidores de descarboxilasa y granulos de l-dopa. Expired - Lifetime ES2052681T5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3744646 1987-12-31

Publications (2)

Publication Number Publication Date
ES2052681T3 true ES2052681T3 (es) 1994-07-16
ES2052681T5 ES2052681T5 (es) 1997-12-01

Family

ID=6343914

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88120859T Expired - Lifetime ES2052681T5 (es) 1987-12-31 1988-12-14 Combinacion sinergica de inhibidores de descarboxilasa y granulos de l-dopa.

Country Status (13)

Country Link
EP (1) EP0324947B2 (es)
JP (1) JPH0296520A (es)
AT (1) ATE81971T1 (es)
AU (1) AU611512B2 (es)
CA (1) CA1315690C (es)
DE (1) DE3875716D1 (es)
DK (1) DK730488A (es)
ES (1) ES2052681T5 (es)
FI (1) FI886047A7 (es)
GR (2) GR3006182T3 (es)
IE (1) IE62643B1 (es)
NO (1) NO885820L (es)
PT (1) PT89350B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983400A (en) * 1986-06-16 1991-01-08 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
DE4101873C2 (de) * 1991-01-23 1993-12-09 Isis Pharma Gmbh Peroral applizierbare Arzneiform zur Behandlung zentraler Dopaminmangelzustände
US8815950B2 (en) 2003-08-29 2014-08-26 Janssen Biotech, Inc. Pharmaceutical compositions and method of using levodopa and carbidopa
EP2508174A1 (en) * 2011-04-06 2012-10-10 Ljiljana Sovic Brkicic Pharmaceutical composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3557292A (en) * 1968-08-16 1971-01-19 Hoffmann La Roche Compositions and methods for treating parkinson's disease with combinations of l-3,4-dihydroxyphenylalanine and a hydrazine
US3769424A (en) * 1970-10-01 1973-10-30 Merck & Co Inc Composition and method of treating dopamine deficiency in brain tissue
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.

Also Published As

Publication number Publication date
FI886047L (fi) 1989-07-01
ATE81971T1 (de) 1992-11-15
DK730488D0 (da) 1988-12-30
PT89350B (pt) 1993-09-30
AU611512B2 (en) 1991-06-13
GR3024980T3 (en) 1998-01-30
ES2052681T5 (es) 1997-12-01
FI886047A7 (fi) 1989-07-01
NO885820L (no) 1989-07-03
EP0324947B2 (de) 1997-08-20
DE3875716D1 (de) 1992-12-10
IE883894L (en) 1989-06-30
NO885820D0 (no) 1988-12-30
IE62643B1 (en) 1995-02-22
CA1315690C (en) 1993-04-06
AU2758288A (en) 1989-07-06
EP0324947B1 (de) 1992-11-04
JPH0296520A (ja) 1990-04-09
DK730488A (da) 1989-07-01
PT89350A (pt) 1989-12-29
EP0324947A1 (de) 1989-07-26
GR3006182T3 (en) 1993-06-21

Similar Documents

Publication Publication Date Title
PT85055A (pt) Processo para a preparacao de composicoes farmaceuticas contendo ester metilico da levodopa
BG47341A3 (en) Means for regulating plant growth
ES2106112T3 (es) Derivados de indano-2-mercaptoacetilamida con una actividad inhibidora de encefalinasa y de ace.
DK1137416T3 (da) Anvendelse af langkædede N-alkylderivater af deoxynojirimycin til fremstilling af et lægemiddel til behandling af glycolipidophobnings-sygdomme
TR199701490A2 (xx) 3-Hidroksipiridin-2-karbonasitamidester ve bunlar�n imalat�.
DK0460062T3 (da) Huperzin A-analoger
ES2082012T3 (es) Inhibidores de la enzima beta-liasa de aminoacido como desodorantes.
ES2052681T3 (es) Combinacion sinergica de inhibidores de descarboxilasa y granulos de l-dopa.
IL103799A (en) Fish production
IT1306147B1 (it) Derivati di principi attivi ad attivita' terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali
PT862454E (pt) Novas utilizacoes de ctla-8 de mamifero e reagentes relacionados
TR199901206T2 (xx) Diyabetik damar rahats�zl�klar�n�n �nlenmesi i�in bir ila� �retiminde katekol-O-metil transferaz inhibit�rlerinin kullan�lmas�.
ES283591Y (es) Una tableta de dosificacion farmaceutica adecuada para administracion oral
PT711163E (pt) Utilizacao de benzidamina no tratamento de estados patologicos provocados por tnf
IT1216096B (it) L_piroglutamil_l_cisteina, dipeptide ad elevata attivita'anticatarattogena e composizioni farmaceutiche che lo contengono.
TR199801887A2 (xx) Bir Na+/H+ - de�i�tiricisi inhibit�r�.
SE8802323L (sv) 8alfa-acylaminoergolin, dess framstaellning samt farmaceutiska kompositioner innehaallande detsamma
ES2051788T3 (es) Un producto farmaceutico.
TW333453B (en) Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases
IL110888A (en) Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound
EP0202986A3 (en) Use of "naftidrofuryl" in the treatment of neuropathies
ATE11639T1 (de) Pharmazeutische zusammensetzungen zur schmerzbekaempfung.
MD346G2 (ro) Picoliden-4-izonicotinoilhidrazona dihidrată cu activitate tuberculostatică
IT8882206A0 (it) Prodotto per lo scioglimento del cerume interno dell'orecchio umano.
GEP19991781B (en) Means for Treatment of Prostate Diseases

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 324947

Country of ref document: ES